Merit Financial Group »

Fate Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $21k 18k 1.20

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Us Gwt (IUSG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Vlu (IUSV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Value Etf (VTV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Mega Cap Val Etf (MGV)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Blackrock Etf Trust Ishares Intl Ctr (CORO)

View all positions for Merit Financial Group

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Two Sigma Investments
Vestal Point Capital
Two Sigma Advisers
Dimensional Fund Advisors
Point72 Asset Management
Goldman Sachs Group
Tang Capital Management

View all funds holding Fate Therapeutics